´ëÇѵÎÅëÇÐȸ 2022Ãß°èÇмú´ëȸ : 2022-11-27±³À°ÀÏÀÚ : 2022-11-27
±³À°Àå¼Ò : ¼¿ïµå·¡°ï½ÃƼȣÅÚ ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ
±³À°ÁÖÁ¦ :
´ëÇѵÎÅëÇÐȸ 2022Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѵÎÅëÇÐȸ
´ã´çÀÚ : ÀåÁ¤¹®
¿¬¶ôó : 02-6411-7331
À̸ÞÀÏ :
khs.secretariat@innon.co.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°ÀÇÇаú, ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 9 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:10~09:30 Migraine pathophysiology and diagnostics Á¶¼öÇö(À»ÁöÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:30~09:50 Migraine therapeutics: real-world data of CGRP, gepant, others ¹®Èñ¼ö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:50~10:10 Cluster headache and other primary headache À̹ÌÁö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:10~10:30 Secondary headaches ±èÁö¿µ(ºÎ»êÀÇ´ë)
ÈÞ½Ä 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:30~10:50 Coffee Break -(-)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:50~11:10 Refractory chronic migraine: How to diagnoses and treat it? ¿À°æ¹Ì(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:10~11:25 Persistent headache after COVID-19 headache or vaccination ¼ÛÅÂÁø(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:25~11:40 Treatment strategies for medication-overuse headache ¼ÕÁ¾Èñ(ÇѸ²ÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:40~12:00 Panel discussion ÀÌÀ±Áø(ºÎ»êÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:40~12:00 Panel discussion ÀÌ¿ø¿ì(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:40~12:00 Panel discussion ¿À°æ¹Ì(°í·ÁÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:40~12:00 Panel discussion ¼ÛÅÂÁø(ÀÌÈÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:40~12:00 Panel discussion ¼ÕÁ¾Èñ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:00~12:20 ´ëÇк´¿ø¿¡¼ÀÇ µÎÅë Ŭ¸®´ÐÀÇ ¿î¿µ ¹ÚÈ«±Õ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:20~12:40 °³¿ø°¡¿¡¼ÀÇ µÎÅë Ŭ¸®´ÐÀÇ ¿î¿µ ÃÖÀ±ÁÖ(ÃÖÀ±ÁֽŰæ°ú)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:40~13:00 µÎÅëȯÀÚ¿¡¼ ¹°¸®Ä¡·á, µµ¼öÄ¡·áÀÇ Àû¿ë ±èº´¼ö(ºÐ´çÁ¦»ýº´¿ø)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:00~13:20 Panel discussion Á¤Áø»ó(Á¤Áø»ó½Å°æ°ú)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:00~13:20 Panel discussion ¹ÚÈ«±Õ(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:00~13:20 Panel discussion ÃÖÀ±ÁÖ(ÃÖÀ±ÁֽŰæ°ú)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:00~13:20 Panel discussion ±èº´¼ö(ºÐ´çÁ¦»ýº´¿ø)
ÈÞ½Ä 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:20~13:30 µÎÅëÇÐȸÁö ¿ì¼ö ¿¬±¸ÀÚ»ó ½Ã»ó½Ä -(-)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:30~13:50 Secondary headache in pregnancy ±è¼ö°æ(°æ»óÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:50~14:10 Headache in stroke, moyamoya disease, giant cell arteritis Á¤ÇÊ¿í(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:10~14:30 Secondary headache in children and adolescents ±ÇÇýÀº(°¡Å縯 °üµ¿ÀÇ´ë)
ÈÞ½Ä 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:30~14:50 Coffee Break -(-)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:50~15:20 Critical presentation of cervicogenic headache Henrik Winther Schytz(Danish Headache Center University of Copenhagen Denmark)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:20~15:30 Q&A -(-)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:30~16:15 µÎÅëÀÇ ½Å°æÂ÷´Ü¼ú Ä¡·á ¹è´ë¿õ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 16:15~17:00 ¸¸¼ºÆíµÎÅëÀÇ º¸Åø¸®´®µ¶¼Ò Ä¡·á ¼Á¾±Ù(°æºÏÀÇ´ë)
Åä·Ð 11-27 ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 17:00~17:10 Q&A -(-)